跳至主要内容
临床试验/NCT07455175
NCT07455175尚未招募不适用

Observational Clinical Study on the Association Between Lactate-mediated Gut Microbiota Alterations and Disease Progression in Liver Cirrhosis.

Zhujiang Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2026年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
200
试验地点
1
主要终点
Gut microbiota composition

研究概览

简要总结

To investigate the association between lactate-mediated alterations in the gut microbiota and disease progression in patients with liver cirrhosis; and to examine the correlations of lactate levels among serum, fecal, and tissue samples in patients with liver cirrhosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy individuals without a history of liver disease or related underlying disorders; or patients diagnosed with liver cirrhosis and its complications based on imaging and/or liver biopsy, with a history of chronic liver disease for more than 6 months. Etiologies include chronic hepatitis B virus infection, nonalcoholic fatty liver disease, and alcoholic liver disease, among others.
  • 2. Willing to participate in this study and able to provide written informed consent.

排除标准

  • 1. A history of severe organic diseases involving the liver, gastrointestinal tract, kidneys, or other organ systems; malignant tumors; or autoimmune diseases.
  • 2. Patients with acute infection or inflammatory diseases within the past 1 month.
  • 3. Pregnant or breastfeeding women.

研究组 & 干预措施

Cirrhosis

干预措施: observational study, no intervention (Other)

Healthy control

干预措施: observational study, no intervention (Other)

结局指标

主要结局

Gut microbiota composition

时间窗: baseline

Lactate level

时间窗: baseline

次要结局

未报告次要终点

研究者

发起方
Zhujiang Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验